ALLERGEN-INDUCED BIPHASIC PLASMA EXUDATION RESPONSES IN GUINEA-PIG LARGE AIRWAYS

In this study involving sensitized guinea pigs (anesthetized intramuscularly with a 3:2 mixture of ketamine + xylazine, 1 ml/kg), we applied allergen (ovalbumin) selectively to the tracheobronchial mucosa (sparing the nasal passages and the terminal airways) and examined the occurrence of immediate and late-phase inflammatory exudation of plasma and plasma-derived mediators (bradykinins) into the airway lumen. The experiments were terminated 10 to 480 min after challenge. A selective lavage that sampled the surface liquids of the extrapulmonary bronchi and the lower trachea was performed. The amount of plasma (mul) was determined by analysis of a plasma tracer, [I-125]albumin, in lavage fluid and blood (plasma) samples. Ovalbumin, 3 to 12 pmol, and histamine, 5 and 10 nmol, produced a dose-dependent immediate exudation response (p < 0.001). The effects were nonneurogenic because they were not affected by topical lidocaine given in a dose (3 nmol) that prevented the exudative effect of capsaicin. The 6- and 12-pmol doses of ovalbumin (but not 3 pmol) produced a significant late-phase exudative response at 5 h (p < 0.001), and both the immediate and late phases were associated with increased (p < 0.01 to p < 0.001) levels of bradykinin in the lavage fluids. Histamine, even in doses that produced a greater early response than the allergen, did not produce a late-phase response. A single topical dose of an antiasthma steroid (budesonide, 12 mumol/kg) administered just before ovalbumin (6 pmol) had little effect on the immediate response but inhibited the late-phase response (p < 0.01). The present observations agree with findings in human allergic asthma. We suggest that mucosal exudation of plasma and plasma-derived mediators is a measure of inflammatory airway response and that the present guinea pig model may be useful in asthma research because it does not involve nasal and pulmonary responses but is specific to tracheobronchial airways.